SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2
SIT LESS 2
2 other identifiers
interventional
19
1 country
1
Brief Summary
Introduction: Changes in lifestyle are responsible for an important part of the type 2 diabetes epidemic of the last decennia. Current guidelines for physical activity focus mainly on high energy expenditure advising 30 minutes per day moderate to vigorous physical activity (most often physical exercise). Recent studies suggest that sitting has negative metabolic effects independent of the time spent exercising (Duvivier et al. PLOS ONE 2013). Low intensity physical activity (LIPA) -such as walking and standing- has been suggested to be an alternative to decrease the hyperglycaemic effect of sitting. Compared to exercise, LIPA might be a more feasible strategy. But, it remains to be determined whether reducing sitting time by replacing it by LIPA, results in lower 24 hour blood glucose levels and less blood glucose fluctuations (glycaemic variability) in type 2 diabetes patients and whether these effects are independent of the increase in energy expenditure Methods: The study population will involve 19 people with type 2 diabetes (BMI: 25-35 kg/m2) who perform no, or only little, exercise and who are treated with diet only or with oral blood glucose lowering medication. They will perform three regimes of each four days: 1) a sitting regime, 2) an exercise regime and a 3) sit less regime. Daily energy expenditure of the exercise regime will be identical to that of the sit less regime. Sitting, walking and standing will be objectively measured by a 24 hour physical activity monitor. The energy spent during exercise will be standardised and quantified by using a bicycle ergometer; energy intake will be standardised as well. During each regime blood glucose will be measured with a 24 hour continuous glucose sensor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable type-2-diabetes
Started Feb 2015
Shorter than P25 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2015
CompletedStudy Start
First participant enrolled
February 1, 2015
CompletedFirst Posted
Study publicly available on registry
February 25, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedMarch 16, 2016
March 1, 2016
3 months
January 22, 2015
March 15, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean 24 hour glucose concentration
during the last 24 hours of an activity regime
Secondary Outcomes (21)
Total duration (minutes) of hyperglycaemia (glucose > 10 mmol/L)
during the last 24 hours of an activity regime
Mean 24 hour glucose concentration
during a whole activity regime
Total duration of hyperglycaemia (glucose > 10 mmol/L)
during a whole activity regime
Area under the curve of hyperglycaemia (glucose > 10 mmol/L)
during the last 24 hours of an activity regime
Glucose variability measured as SD divided by mean
the last 24 hours of each regime
- +16 more secondary outcomes
Study Arms (3)
Sitting regime
EXPERIMENTALThe subjects will follow the sitting regime during four days. Each day: 14 hours sitting, 1 hour walking and 1 hour standing for daily care and 8 hours sleeping or lying.
Sit Less regime
EXPERIMENTALSubjects will follow the sit less regime during four days. Each day will consist of 3 hours walking, 4 hours standing, 9 hours sitting and 8 hours sleeping or lying. The additional 2 hours of walking and 3 hours of standing, compared to the sitting regime, will be done in a minimum of four bouts with a time interval of \> 1 hour. The subjects will be instructed to walk on a slow pace. i.e. 2-3 km/h, which is comparable to walking during shopping, walking to the office etc.
Exercise regime
EXPERIMENTALSubjects will follow the exercise regime during four days. Each day will consist of 13 hours and 15 minutes sitting, ± 45 minutes supervised cycling on an ergometer, 1 hour walking and 1 hour standing for daily care and 8 hours sleeping or lying.
Interventions
Eligibility Criteria
You may qualify if:
- Signed informed consent
- Men and women: 40-75 years old
- Diabetes mellitus type 2, developed after the age of 40 years old
- Treatment with diet or oral blood glucose lowering medication (metformin and/or SU-derivatives and/or DPP-IV inhibitors)
- HbA1c: \< 10%
- BMI: 25.0 - 35.0 kg/m2
- Maximum 2.5 hours of MVPA per week (during last 3 months)
- Internet availability on a daily basis
You may not qualify if:
- Pregnancy or intention of becoming pregnant
- Alcohol use: \> 2 units per day (during the last 3 months)
- Experimental drug use (during the last 3 months)
- Use of insulin, corticosteroids, vitamin K antagonists and immunosuppressive drugs in the last 3 months
- Triglyceride level \> 10.0 mmol/L
- Fasting plasma glucose level \> 10 mmol/L
- Heart failure NYHA 3 or higher
- Angina pectoris or signs of cardiac ischemia during exercise testing
- COPD Gold 3 or higher
- Glomerular filtration rate (GFR) \< 30 ml/min
- Diagnosis of active cancer (not cancer in the past that is cured)
- Diabetes mellitus type 1
- Intermittent claudication with a walking distance \< 500 meter
- Not able to cycle for ± 45 minutes, as judged from the incremental exhaustive exercise bicycle-ergometer test at Visit 1
- Based on historical information not able to walk for 3 hours per day and stand for 4 hours per day
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maastricht University Medical Centerlead
- Novo Nordisk A/Scollaborator
Study Sites (1)
Human Movement Science, Maastricht University
Maastricht, Limburg, 6200 MD, Netherlands
Related Publications (2)
Duvivier BM, Schaper NC, Bremers MA, van Crombrugge G, Menheere PP, Kars M, Savelberg HH. Minimal intensity physical activity (standing and walking) of longer duration improves insulin action and plasma lipids more than shorter periods of moderate to vigorous exercise (cycling) in sedentary subjects when energy expenditure is comparable. PLoS One. 2013;8(2):e55542. doi: 10.1371/journal.pone.0055542. Epub 2013 Feb 13.
PMID: 23418444BACKGROUNDDuvivier BM, Schaper NC, Hesselink MK, van Kan L, Stienen N, Winkens B, Koster A, Savelberg HH. Breaking sitting with light activities vs structured exercise: a randomised crossover study demonstrating benefits for glycaemic control and insulin sensitivity in type 2 diabetes. Diabetologia. 2017 Mar;60(3):490-498. doi: 10.1007/s00125-016-4161-7. Epub 2016 Nov 30.
PMID: 27904925DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicolaas C Schaper, MD PhD
Maastricht University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2015
First Posted
February 25, 2015
Study Start
February 1, 2015
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
March 16, 2016
Record last verified: 2016-03